CompletedNCT00224510
This study is completed. It focuses on bipolarity and currently lists study information in the Netherlands and Spain.
Multiple locations, including AlkmaarBipolarity, DepressionDrugA study involving a medication or substance.Over 18 Years
- Countries
- Netherlands, Spain
- Sponsor
- GlaxoSmithKline
- Condition
- Bipolarity, Depression
CompletedNCT03403790
This study is completed. It focuses on bipolarity and currently lists study information in Japan.
Multiple locations, including AichiBipolarity, DepressionDrug
- Countries
- Japan
- Sponsor
- Astellas Pharma Inc
- Condition
- Bipolarity, Depression
CompletedNCT04612777
This study is completed. It focuses on depression and currently lists study information in Global.
In GlobalDepression, Schizophrenia, ...BehavioralFrom 18 Years to 65 Years
- Countries
- Global
- Sponsor
- New York State Psychiatric Institute
- Condition
- Depression, Schizophrenia, ...
WithdrawnNCT02476331
This study has public registry information. It focuses on bipolarity and currently lists study information in Canada.
In CalgaryBipolarityBehavioralFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Calgary
- Condition
- Bipolarity
CompletedNCT04030143
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
Multiple locations, including Little RockBipolarity, SchizophreniaDrugFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity, Schizophrenia
CompletedNCT00762268
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In BelmontBipolarity, DepressionDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Bipolarity, Depression
CompletedNCT03854409
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
Multiple locations, including Little RockBipolarity, SchizophreniaDrugFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity, Schizophrenia
CompletedNCT06229977
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In HoustonBipolarity, DepressionDrugFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Bipolarity, Depression
CompletedNCT06372210
This study is completed. It focuses on depression and currently lists study information in the United States.
In Garden GroveDepression, Schizophrenia, ...DrugOver 18 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Depression, Schizophrenia, ...
CompletedNCT03259555
This study is completed in the United States, in Bulgaria, in Poland, .... It focuses on manic episodes in bipolarity type I.
Multiple locations, including Little RockBipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States, Bulgaria, Poland, ...
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity
CompletedNCT03257865
This study is completed in the United States, in Croatia, and in Ukraine. It focuses on manic episodes in bipolarity type I.
Multiple locations, including Little RockBipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States, Croatia, Ukraine
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity
CompletedNCT03287869
This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing brexpiprazole for Bipolarity.
Multiple locations, including Little RockBipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States, Bulgaria, Croatia, ...
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Bipolarity
